Fibrinolytic Activity of Veins in the Puerperium

References

• Abildgaard U., Uszynski M. Separation and characterization of two fibrinolytic inhibitors from human placenta. Thrombos Diathes Hacmorrh 1971; 25: 580
   Google Scholar
• Biezenski J. J., Moore H. C. Fibrinolysis in normal pregnancy. J Clin Path 1958; 11: 306
   PubMed Web of Science ®Google Scholar
• Bonnar J., McNicol G. P., Dougias A. S. Fibrinolytic enzyme system and pregnancy. Brit Med J 1969; 3: 387
   PubMed Web of Science ®Google Scholar
• Bonnar J., McNicol G. P., Douglas A. S. Coagulation and fibrinolytic mechanisms during and after childbirth. Brit Med J 1970; 2: 200
   PubMed Web of Science ®Google Scholar
• Brakman P. The fibrinolytic system in human blood during pregnancy. Amer J Obstel Gynec 1966; 94: 14
   PubMed Web of Science ®Google Scholar
• Brakman P. Fibrinolysis. A standardized fibrin plate method and a fibrinolytic assay of plasminogen. Scheltema & Holkema, Amsterdam 1967
   Google Scholar
• Brakman P., Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand J Clin Lab Invest 1963; 15: 603
   PubMed Web of Science ®Google Scholar
• Correll J. T., Sjoerdsma A. Inhibition of a human fibrinolytic system by normal and pathologic sera. Proc Soc Exp Biol (NY) 1962; 111: 214
   Google Scholar
• Ekelund H., Hedner U., Nilsson I. M. Fibrinolysis in newborns. Acta Paediat Scand 1970; 59: 33
   PubMed Web of Science ®Google Scholar
• Ganrot P. O. Determination of α2-macroglobulin as trypsin-protein esterase. Clin Chim Acta 1966; 14: 493
   PubMed Web of Science ®Google Scholar
• Ganrot P. O., Niléhn J.-E. Immunochemical determination of human plasminogen. Clin Chim Acta 1968; 22: 335
   PubMed Web of Science ®Google Scholar
• Gillman T., Naidoo S. S., Hathorn M. Plasma fibrinogen activity in pregnancy. Lancet 1959; 11: 70
   Google Scholar
• Hedner U., Åstedt B. Studies on fibrinolytic inhibitors during pregnancy. Acta Obslel Gynec Scand 1971; 50: 99
   PubMed Web of Science ®Google Scholar
• Isacson S. Effect of prednisolone on the coagulation and fibrinolytic systems. Scand J Haemal 1970; 7: 212
   Google Scholar
• Kawano T., Morimoto K., Uemura Y. Urokinase inhibitor in human placenta. Nature 1968; 217: 253
   PubMed Web of Science ®Google Scholar
• Lauritsen O. S. The fibrinolytic enzyme system of human blood plasma in pregnancy. Scand J Clin Lab Invest 1969; 23: 191
   PubMed Web of Science ®Google Scholar
• Niléhn J.-E. Separation and estimation of “split products” of fibrinogen and fibrin in human serum. Thrombos Diathes Haemorrh 1967; 18: 487
   PubMedGoogle Scholar
• Nilsson I. M., Kullander S. Coagulation and fibrinolytic studies during pregnancy. Acta Obslet Gynec Scand 1967; 46: 273
   PubMed Web of Science ®Google Scholar
• Nilsson I. M., Olow B. Determination of fibrinogen and fibrinogenolylic activity. Thrombos Diathes Haemorrh 1962; 8: 297
   PubMedGoogle Scholar
• Nilsson I. M., Pandolfi M. Fibrinolytic response of the vascular wall. Thrombos Diathes Haemorrh, Suppl. 1970; 40: 231
   Google Scholar
• Pandolfi M., Åstedt B., Nilsson I. M. Hislochcmical assay of tissue plasminogen activator in vein walls—a standard method. Thrombos Diathes Haemorrh
   Google Scholar
• Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Lab Invest 1962; 14: 138
   PubMed Web of Science ®Google Scholar
• Robertson B. R. On thrombosis, thrombolysis and fibrinolysis. Acta Chir Scand 1971, Suppl. 421
   Google Scholar
• Shamash Y., Rimon A. The plasmin inhibitors of plasma. 1. A method for their estimation. Thrombos Diathes Haemorrh (Stuttg.) 1964; 12: 119
   PubMedGoogle Scholar
• Shaper A. G., Kear J., Macintosh D. M., Kyobe J., Njama D. The platelet count, platelet adhesiveness and aggregation and the mechanism of fibrinolytic inhibition in pregnancy and the puerperium. J Obstet Gynaec Brit Comm 1968; 75: 433
   PubMedGoogle Scholar
• Shaper A. G., Macintosh D. M., Evans C. M., Kyobe J. Fibrinolysis and plasminogen levels in pregnancy and the puerperium. Lancet 1965; 11: 706
   Google Scholar
• Shaper A. G., Macintosh D. M., Kyobe J. Fibrinolytic activity in pregnancy, during parturition, and in the puerperium. Lancet 1966; 11: 874
   Google Scholar
• Stiehm E. R., Kennan A. L., Schelble D. T. Split products of fibrin in maternal serum in the perinatal period. Amer J Obstet Gynec 1970; 108: 941
   Google Scholar
• Todd A. S. Histological localization of fibrinolysin activator. J Path Bact 1959; 78: 281
   PubMedGoogle Scholar
• Ygge J. Changes in blood coagulation and fibrinolysis during the puerperium. Amer J Obstet Gynec 1969; 104: 2
   Google Scholar
• Åstedt B. Low fibrinolytic activity of veins during treatment with elhinyloestradiol. Acta Obstet Gynec Scand 1971; 50: 279
   PubMed Web of Science ®Google Scholar
• Åstedt B. Demonstration of significance of placenta in depression of fibrinolytic activity during pregnancy. J Obstet Gynaec Brit Comm
   Google Scholar
• Åstedt B. Fibrinolytic activity during labour. Acta Obstet Gynec Scand
   Google Scholar
• Åstedt B., Isacson S., Nilsson I. M., Pandolfi M. Fibrinolytic activity of veins during pregnancy. Acta Obstet Gynec Scand 1970; 49: 171
   PubMed Web of Science ®Google Scholar
• Åstedt B., Pandolfi M., Nilsson I. M. Inhibitory effect of placenta on plasminogen activation in human organ culture. Proc Soc Exp Biol Med
   Google Scholar